IO BIOTECH INC (IOBT) Stock Income Statement
USA - NASDAQ:IOBT - US4497781090 - Common Stock
1.58 USD
0 (0%)
1.6 USD
+0.02 (+1.27%)
| TTM (2025-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 99.20M | 91.44M | 71.42M | 41.23M | 10.15M | |||
| Research and Development | 74.35M | 67.83M | 46.99M | 30.15M | 8.46M | |||
| Selling, General, and Administrative Expenses | 24.85M | 23.61M | 24.44M | 11.08M | 1.68M | |||
| Operating Income | -99.20M | -91.44M | -71.42M | -41.23M | -10.15M | |||
| Interest Income/Expense | -3.87M | 6.21M | 1.24M | -40.00K | -1.90M | |||
| Other Income/Expense | N/A | N/A | 0.00 | -26.54M | N/A | |||
| Income Before Taxes | -103.07M | -85.23M | -70.19M | -67.81M | -12.04M | |||
| Income Tax | 918.00K | 852.00K | 1.27M | 70.00K | 0.00 | |||
| Net Income | -103.99M | -86.08M | -71.46M | -74.99M | -14.59M | |||
| EBITDA | -98.95M | -91.23M | -71.32M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.58 | -1.98 | -2.48 | -2.60 | -0.53 | |||
| Non GAAP EPS | -1.53 | -2.16 | -2.50 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD